pcDNA3.1-SARS-Spike Citations (8)
Originally described in: Structural basis of receptor recognition by SARS-CoV-2.Shang J, Ye G, Shi K, Wan Y, Luo C, Aihara H, Geng Q, Auerbach A, Li F Nature. 2020 Mar 30. pii: 10.1038/s41586-020-2179-y. doi: 10.1038/s41586-020-2179-y. PubMed Journal
Articles Citing pcDNA3.1-SARS-Spike
Articles |
---|
Mechanisms of SARS-CoV-2 neutralization by shark variable new antigen receptors elucidated through X-ray crystallography. Ubah OC, Lake EW, Gunaratne GS, Gallant JP, Fernie M, Robertson AJ, Marchant JS, Bold TD, Langlois RA, Matchett WE, Thiede JM, Shi K, Yin L, Moeller NH, Banerjee S, Ferguson L, Kovaleva M, Porter AJ, Aihara H, LeBeau AM, Barelle CJ. Nat Commun. 2021 Dec 16;12(1):7325. doi: 10.1038/s41467-021-27611-y. PubMed |
Evolutionary pathways to SARS-CoV-2 resistance are opened and closed by epistasis acting on ACE2. Castiglione GM, Zhou L, Xu Z, Neiman Z, Hung CF, Duh EJ. PLoS Biol. 2021 Dec 21;19(12):e3001510. doi: 10.1371/journal.pbio.3001510. eCollection 2021 Dec. PubMed |
An antibody that neutralizes SARS-CoV-1 and SARS-CoV-2 by binding to a conserved spike epitope outside the receptor binding motif. Fang Y, Sun P, Xie X, Du M, Du F, Ye J, Kalveram BK, Plante JA, Plante KS, Li B, Bai XC, Shi PY, Chen ZJ. Sci Immunol. 2022 Oct 28;7(76):eabp9962. doi: 10.1126/sciimmunol.abp9962. Epub 2022 Oct 28. PubMed |
SARS-CoV-2 down-regulates ACE2 through lysosomal degradation. Lu Y, Zhu Q, Fox DM, Gao C, Stanley SA, Luo K. Mol Biol Cell. 2022 Dec 1;33(14):ar147. doi: 10.1091/mbc.E22-02-0045. Epub 2022 Oct 26. PubMed |
Convergent activation of two-pore channels mediated by the NAADP-binding proteins JPT2 and LSM12. Gunaratne GS, Brailoiu E, Kumar S, Yuan Y, Slama JT, Walseth TF, Patel S, Marchant JS. Sci Signal. 2023 Aug 22;16(799):eadg0485. doi: 10.1126/scisignal.adg0485. Epub 2023 Aug 22. PubMed |
The SARS-CoV-2 spike glycoprotein interacts with MAO-B and impairs mitochondrial energetics. Pileggi CA, Parmar G, Elkhatib H, Stewart CM, Alecu I, Cote M, Bennett SAL, Sandhu JK, Cuperlovic-Culf M, Harper ME. Curr Res Neurobiol. 2023 Oct 6;5:100112. doi: 10.1016/j.crneur.2023.100112. eCollection 2023. PubMed |
Calreticulin Regulates SARS-CoV-2 Spike Protein Turnover and Modulates SARS-CoV-2 Infectivity. Rahimi N, White MR, Amraei R, Lotfollahzadeh S, Xia C, Michalak M, Costello CE, Muhlberger E. Cells. 2023 Nov 23;12(23):2694. doi: 10.3390/cells12232694. PubMed |
Development and utility of a SARS-CoV-2 pseudovirus assay for compound screening and antibody neutralization assays. Manu AA, Owusu IA, Oyawoye FO, Languon S, Barikisu IA, Tawiah-Eshun S, Quaye O, Donkor KJ, Paemka L, Amegatcher GA, Denyoh PMD, Oduro-Mensah D, Awandare GA, Quashie PK. Heliyon. 2024 May 19;10(10):e31392. doi: 10.1016/j.heliyon.2024.e31392. eCollection 2024 May 30. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.